Skip to main content
. 2022 Jun 21;12:97. doi: 10.1186/s13578-022-00833-3

Table 2.

Overview of cellular functions of circRNAs in pancreatic cancer

No Circ Host gene Vitro Functions Specimen Expression Reference
Prolife Cycle Apopt Migra Invas Angio Other
1 ciRS7 CDR1as + + BXPC3/PANC1 Up 30,898,507
2 0000284 HIPK3 + BXPC3 Up 29,255,366
3 0005273 PTK2 + + ASPC1/CFPAC1 Up 33,275,224
4 chr12:7,467,880,474,700,449 + BXPC3 Up 32,879,441
5 0001649 SHPRH + + BXPC3/PANC1 Down 29,969,694
6 ASH2L ASH2L + + + + + CAPAN1/ASPC1 Up 31,718,694
7 0001460 NEIL3 + + + + CFPAC1/MIAPACA2 Up 33,750,389
8 0013912 POLR3C + + + + + ASPC1/PANC1 Up 32,884,344
9 0050102 PGPEP1 + + + + + CFPAC1/PANC1 Up 33,289,016
10 0000662 AXIN1 + + + + + ASPC1 Down 33,425,718
11 0000677 ABCC1 + + + + ASPC1/BXPC3 Up 33,413,045
12 0007534 DDX42 + + + PANC1/SW1990 Up 30,382,592
13 0001946 CDR1as + + + + ASPC1/PANC1 Up 33,593,338
14 0006215 SLC4A7 + + + PANC1 Up 29,930,719
15 0060055 EIF6 + + + + HS766T/SW1990 Up 33,469,368
16 0066147 SFMBT1 + + + + BXPC3/PANC1 Up 32,855,541
17 0071036 INPP4B + + + ASPC1/PANC1 Up 33,507,122
18 0099999 ZMYM2 + + + CFPAC1/PANC1 Up 30,537,731
19 IARS IARS Endothelial permeability Exo-HUVEC/ASPC1/HS766T/HS766T-L2 Up 30,064,461
20 0036627 PDE8A + + + + Scatteration BXPC3/CAPAN2/Exo-HS766T Up 29,709,702
21 ADAM9 ADAM9 + + + CAPAN1/MIAPACA2 Up 31,810,373
22 0000069 STIL + + + + + MIAPACA2/SW1990; Exo-HPDE/SW1990 Up 33,324,055
23 0009065 BFAR + + + BXPC3/PANC1 Up 32,375,768
24 0043278 TADA2A + + + PANC1/SW1990 Up 33,505,218
25 0075829 CASC15 + + + BXPC3/SW1990 Up 33,184,989
26 chr7:154,954,255,154,998,784 + + + PANC1 + NAPSC/CAPSC Up 33,042,405
27 LDLRAD3 LDLRAD3 + + + PANC1/SW1990 Up 31,521,692
28 0001013 KIAA1841 + + + + ASPC1/PANC1 Up 33,563,550
29 0001568 DUSP22 + + + + + BXPC3/CAPAN2 Up 32,193,152
30 0000979 TCONS_00003590 + + + + PANC1 Down 32,878,470
31 0086375 NFIB + + CAPAN2/PANC1 Down 32,366,257
32 circ 03955 + + Glycolysis BXPC3/PANC1 Up 33,864,618
33 0007334 MBOAT2 + + + + Glutamine metabolism PANC1/SW1990 Up 33,832,516
34 0000977 NOL10 Inhibition of NK cells under hypoxia PANC1/NK cell Induced by hypoxiain 31,402,756
35 0007367 UBAP2 Immune infiltration GSE69362 and GSE79634 Up 31,584,877
36 0002130 C3 PANC1/SW1990; PDX tumor Up 32,727,565
37 0092314 RANBP1 + + CSC ASPC1/PACA2 Up 33,842,379
38 0005397 RHOT1 + + + CAPAN2/PANC1 Up 30,444,423
39 0007334 MBOAT2 + PANC1 31,428,151
40 0030235 RCBTB2 + + + + PANC1/SW1990 Up 30,591,218
41 0000816 FOXK2 + + + + + CFPAC1/PANC1 Up 32,217,695
42 0006988 LDLRAD3 ASPC1/CAPAN2/HPCY5/HPDE6C7/PANC1/SW1990 Up 29,307,994
43 chr14:101,402,109,101,464,448 SNHG23 + GEM-resistance PANC1-GEM Up 29,922,161
44 chr4:5,272,960,352,780,244 DCUN1D4 + GEM-resistance PANC1-GEM Up 29,922,161
45 0000284 HIPK3 + + + + GEM-resistance PANC1/SW1990-GEM Up 32,104,074
46 101672/004077/003251 GEM-resistance SW1990-GEM Up 29,781,033
47 101543/002747/000926 GEM-resistance SW1990-GEM Down 29,781,033

Prolife: Proliferation; Cycle: Cell cycle; Apopt: Apoptosis; Migra: Migration; Invas: Invasion; Angio: Angiogenesis; CSC: Cancer Stem Cell; GEM: Gemcitabine